Skip to main navigation Skip to search Skip to main content

Optimization of physicochemical properties of pyrrolidine GPR40 AgoPAMs results in a differentiated profile with improved pharmacokinetics and reduced off-target activities

  • Elizabeth A. Jurica
  • , Ximao Wu
  • , Kristin N. Williams
  • , Lauren E. Haque
  • , Richard A. Rampulla
  • , Arvind Mathur
  • , Min Zhou
  • , Gary Cao
  • , Hong Cai
  • , Tao Wang
  • , Heng Liu
  • , Carrie Xu
  • , Lori K. Kunselman
  • , Thomas M. Antrilli
  • , Michael B. Hicks
  • , Qin Sun
  • , Elizabeth A. Dierks
  • , Atsu Apedo
  • , Douglas B. Moore
  • , Kimberly A. Foster
  • Mary Ellen Cvijic, Reshma Panemangalore, Purnima Khandelwal, Jason J. Wilkes, Bradley A. Zinker, Donald G. Robertson, Evan B. Janovitz, Michael Galella, Yi Xin Li, Julia Li, Thangeswaran Ramar, Prasada Rao Jalagam, Ramya Jayaram, Jean M. Whaley, Joel C. Barrish, Jeffrey A. Robl, William R. Ewing, Bruce A. Ellsworth
  • Bristol-Myers Squibb

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number117273
JournalBioorganic and Medicinal Chemistry
Volume85
DOIs
StatePublished - May 1 2023
Externally publishedYes

ASJC Scopus Subject Areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Keywords

  • AgoPAM
  • Chirality
  • FFAR1
  • GLP-1
  • GPR40
  • Hyperglycemia
  • Polarity
  • Pyrrolidine
  • Saturation
  • Type 2 diabetes

Fingerprint

Dive into the research topics of 'Optimization of physicochemical properties of pyrrolidine GPR40 AgoPAMs results in a differentiated profile with improved pharmacokinetics and reduced off-target activities'. Together they form a unique fingerprint.

Cite this